2,067
Views
65
CrossRef citations to date
0
Altmetric
Brief Report

Platelet-mediated shedding of NKG2D ligands impairs NK cell immune-surveillance of tumor cells

, , ORCID Icon, ORCID Icon, , , , , & show all
Article: e1364827 | Received 08 Feb 2017, Accepted 03 Aug 2017, Published online: 27 Nov 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Daniel Cacic, Tor Hervig & Håkon Reikvam. (2023) Platelets for advanced drug delivery in cancer. Expert Opinion on Drug Delivery 20:5, pages 673-688.
Read now

Articles from other publishers (63)

Xiuxiu Zhang, Sheng Qiu & Cailian Wang. (2024) The Tumor Microenvironment Affects Circulating Tumor Cells Metastasis and the Efficacy of Immune Checkpoint Blockade in Non-small Cell Lung Cancer. Current Cancer Drug Targets 24:1, pages 2-13.
Crossref
Lin Zhou, Zhe Zhang, Yizhou Tian, Zefei Li, Zhongliang Liu & Sibo Zhu. (2023) The critical role of platelet in cancer progression and metastasis. European Journal of Medical Research 28:1.
Crossref
Yuanyuan Wang, Stefan W. Schneider & Christian Gorzelanny. (2023) Crosstalk between Circulating Tumor Cells and Plasma Proteins—Impact on Coagulation and Anticoagulation. Cancers 15:11, pages 3025.
Crossref
Zihan Ding, Yang Liu, Qinhua Huang, Changhong Cheng, Lining Song, Chen Zhang, Xiaohong Cui, Yan Wang, Yi Han & Haijian Zhang. (2023) m6A‐ and immune‐related lncRNA signature confers robust predictive power for immune efficacy in lung squamous cell carcinoma. VIEW 4:3.
Crossref
Jie Guo, Meng-Fei Wang, Yong Zhu, Fumio Watari, Yong-Hong Xu & Xiao Chen. (2023) Exploitation of platelets for antitumor drug delivery and modulation of the tumor immune microenvironment. Acta Materia Medica 2:2.
Crossref
Yaxin Li, Haiyan Wang, Zhen Zhao, Yuanming Yang, Zifan Meng & Lifeng Qin. (2023) Effects of the interactions between platelets with other cells in tumor growth and progression. Frontiers in Immunology 14.
Crossref
Jie Huang, Aiping Lu & Chao Liang. 2023. Cancer Metastasis - Molecular Mechanism and Clinical Therapy. Cancer Metastasis - Molecular Mechanism and Clinical Therapy.
Angel Charles & Ryan M. Thomas. (2023) The Influence of the microbiome on the innate immune microenvironment of solid tumors. Neoplasia 37, pages 100878.
Crossref
Alessandro Giammona, Enrica Crivaro & Barbara Stecca. (2023) Emerging Roles of Hedgehog Signaling in Cancer Immunity. International Journal of Molecular Sciences 24:2, pages 1321.
Crossref
Hao Dong, Shutao Zhao, Chao Zhang & Xudong Wang. (2023) Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer. Frontiers in Surgery 9.
Crossref
Zeinab Ghazvinian, Shahrokh Abdolahi, Samaneh Tokhanbigli, Shadi Tarzemani, Andrea Piccin, Mohammad Reza Zali, Javad Verdi & Kaveh Baghaei. (2023) Contribution of natural killer cells in innate immunity against colorectal cancer. Frontiers in Oncology 12.
Crossref
Xiulan Bian, Shengjie Yin, Shuo Yang, Xinju Jiang, Jiaqi Wang, Minghui Zhang & Lei Zhang. (2022) Roles of platelets in tumor invasion and metastasis: A review. Heliyon 8:12, pages e12072.
Crossref
Xuewen Deng & Hiroshi Terunuma. (2022) Harnessing NK Cells to Control Metastasis. Vaccines 10:12, pages 2018.
Crossref
Bert Malengier-Devlies, Jessica Filtjens, Kourosh Ahmadzadeh, Bram Boeckx, Jessica Vandenhaute, Amber De Visscher, Eline Bernaerts, Tania Mitera, Cato Jacobs, Lore Vanderbeke, Pierre Van Mol, Yannick Van Herck, Greet Hermans, Philippe Meersseman, Alexander Wilmer, Mieke Gouwy, Abhishek D. Garg, Stephanie Humblet-Baron, Frederik De Smet, Kimberly Martinod, Els Wauters, Paul Proost, Carine Wouters, Georges Leclercq, Diether Lambrechts, Joost Wauters & Patrick Matthys. (2022) Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates. Frontiers in Immunology 13.
Crossref
Ofek Mussafi, Jie Mei, Wenjun Mao & Yuan Wan. (2022) Immune checkpoint inhibitors for PD-1/PD-L1 axis in combination with other immunotherapies and targeted therapies for non-small cell lung cancer. Frontiers in Oncology 12.
Crossref
Savannah R. Free & Kermit L. Carraway. 2022. Breast Cancer. Breast Cancer 101 114 .
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, Laura Córdoba, Elena Maroto-Martín, Jessica Encinas, Alejandra Leivas, Paula Río & Joaquín Martínez-López. (2022) Overcoming tumor resistance mechanisms in CAR-NK cell therapy. Frontiers in Immunology 13.
Crossref
Jianxin Tao, Lei Zhu, Mina Yakoub, Christoph Reißfelder, Sonja Loges & Sebastian Schölch. (2022) Cell–Cell Interactions Drive Metastasis of Circulating Tumor Microemboli. Cancer Research 82:15, pages 2661-2671.
Crossref
Yan-Xin Niu, Zhao-Xu Xu, Li-Feng Yu, Yong-Ping Lu, Yan Wang, Ce Wu, Yi-Bo Hou, Jia-Ning Li, Shengqiang Huang, Xinyue Song, Xinyu Wang, Jiaqi Wang, Binyu Li, Yingrui Guo, Zhaojin Yu, Lin Zhao, Dong-Xu Yi & Min-Jie Wei. (2022) Advances of research of Fc-fusion protein that activate NK cells for tumor immunotherapy. International Immunopharmacology 109, pages 108783.
Crossref
Susanne M. Rittig, Martina S. Lutz, Kim L. Clar, Yanjun Zhou, Korbinian N. Kropp, André Koch, Andreas D. Hartkopf, Martina Hinterleitner, Lars Zender, Helmut R. Salih, Stefanie Maurer & Clemens Hinterleitner. (2022) Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression. Frontiers in Oncology 12.
Crossref
Min Soon Cho, Hani Lee, Ricardo Gonzalez-Delgado, Dan Li, Tomoyuki Sasano, Wendolyn Carlos-Alcalde, Qing Ma, Jinsong Liu, Anil K. Sood & Vahid Afshar-Kharghan. (2022) Platelets Increase the Expression of PD-L1 in Ovarian Cancer. Cancers 14:10, pages 2498.
Crossref
Gerd Bendas & Martin Schlesinger. (2022) The GPIb-IX complex on platelets: insight into its novel physiological functions affecting immune surveillance, hepatic thrombopoietin generation, platelet clearance and its relevance for cancer development and metastasis. Experimental Hematology & Oncology 11:1.
Crossref
Xiaobing Duan, Haiwen Chen, Xiang Zhou, Pingjuan Liu, Xiao Zhang, Qian Zhu, Ling Zhong, Wanlin Zhang, Shanshan Zhang, Xinyu Zhang, Yanhong Chen, Yan Zhou, Chaopin Yang, Qisheng Feng, Yi-Xin Zeng, Miao Xu & Tong Xiang. (2022) EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation. Cancer Research 82:6, pages 1070-1083.
Crossref
Hiroshi Ichise, Shoko Tsukamoto, Tsuyoshi Hirashima, Yoshinobu Konishi, Choji Oki, Shinya Tsukiji, Satoshi Iwano, Atsushi Miyawaki, Kenta Sumiyama, Kenta Terai & Michiyuki Matsuda. (2022) Functional visualization of NK cell-mediated killing of metastatic single tumor cells. eLife 11.
Crossref
E. V. Slukhanchuk, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, A. G. Solopova, V. N. Galkin, A. S. Shkoda, V. I. Tsibizova, V. I. Linnikov, Ismail Elalamy, J.-С. Gris, B. Brenner & A. D. Makatsariya. (2021) Platelets, thrombo-inflammation and cancer. Obstetrics, Gynecology and Reproduction 15:6, pages 755-776.
Crossref
Luis Sánchez-del-Campo, Román Martí-Díaz, María F. Montenegro, Rebeca González-Guerrero, Trinidad Hernández-Caselles, Enrique Martínez-Barba, Antonio Piñero-Madrona, Juan Cabezas-Herrera, Colin R. Goding & José Neptuno Rodríguez-López. (2021) MITF induces escape from innate immunity in melanoma. Journal of Experimental & Clinical Cancer Research 40:1.
Crossref
Danfeng Lin, Lesang Shen, Meng Luo, Kun Zhang, Jinfan Li, Qi Yang, Fangfang Zhu, Dan Zhou, Shu Zheng, Yiding Chen & Jiaojiao Zhou. (2021) Circulating tumor cells: biology and clinical significance. Signal Transduction and Targeted Therapy 6:1.
Crossref
Reza Haschemi, Dennis Kobelt, Elisabeth Steinwarz, Martin Schlesinger, Ulrike Stein & Gerd Bendas. (2021) Insulin-like Growth Factor Binding Protein-2 (IGFBP2) Is a Key Molecule in the MACC1-Mediated Platelet Communication and Metastasis of Colorectal Cancer Cells. International Journal of Molecular Sciences 22:22, pages 12195.
Crossref
James O. Jones, William M. Moody & Jacqueline D. Shields. (2020) Microenvironmental modulation of the developing tumour: an immune‐stromal dialogue. Molecular Oncology 15:10, pages 2600-2633.
Crossref
Brian Hayes, Lauren Brady, Gráinne Sheill, Anne-Marie Baird, Emer Guinan, Bryan Stanfill, Jean Dunne, Dean Holden, Tatjana Vlajnic, Orla Casey, Verena Murphy, John Greene, Emma H. Allott, Juliette Hussey, Fidelma Cahill, Mieke Van Hemelrijck, Nicola Peat, Lorelei A. Mucci, Moya Cunningham, Liam Grogan, Thomas Lynch, Rustom P. Manecksha, John McCaffrey, Dearbhaile M. O’Donnell, Orla Sheils, John J. O’Leary, Sarah Rudman, Ray McDermott & Stephen Finn. (2021) Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21). Cancers 13:18, pages 4690.
Crossref
Attila Braun, Hans-Joachim Anders, Thomas Gudermann & Elmina Mammadova-Bach. (2021) Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues. Frontiers in Oncology 11.
Crossref
Yanjun Zhou, Jonas S. Heitmann, Korbinian N. Kropp, Martina Hinterleitner, André Koch, Andreas D. Hartkopf, Helmut R. Salih, Clemens Hinterleitner & Stefanie Maurer. (2021) Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?. Diagnostics 11:7, pages 1188.
Crossref
Irene Mattiola. (2021) Immune Circuits to Shape Natural Killer Cells in Cancer. Cancers 13:13, pages 3225.
Crossref
Martina Hinterleitner, Bence Sipos, Verena Wagner, Julia M. Grottenthaler, Ulrich M. Lauer, Lars Zender & Clemens Hinterleitner. (2021) Platelet-Expressed Synaptophysin (pSyn) as Novel Biomarker in Neuroendocrine Malignancies. Cancers 13:10, pages 2286.
Crossref
Suchit Jhunjhunwala, Christian Hammer & Lélia Delamarre. (2021) Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nature Reviews Cancer 21:5, pages 298-312.
Crossref
Laurent Schmied, Petter Höglund & Stephan Meinke. (2021) Platelet-Mediated Protection of Cancer Cells From Immune Surveillance – Possible Implications for Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Petr Stepka, Vit Vsiansky, Martina Raudenska, Jaromir Gumulec, Vojtech Adam & Michal Masarik. (2021) Metabolic and Amino Acid Alterations of the Tumor Microenvironment. Current Medicinal Chemistry 28:7, pages 1270-1289.
Crossref
Sophie Curio, Gustav Jonsson & Sonja Marinović. (2021) A summary of current NKG2D-based CAR clinical trials. Immunotherapy Advances 1:1.
Crossref
Hassan Dianat-Moghadam, Amir Mahari, Maryam Heidarifard, Negin Parnianfard, Laleh Pourmousavi-Kh, Reza Rahbarghazi & Zohreh Amoozgar. (2021) NK cells-directed therapies target circulating tumor cells and metastasis. Cancer Letters 497, pages 41-53.
Crossref
Svenja Schwarz, Martin Schlesinger & Gerd Bendas. 2021. Metastasis. Metastasis 181 195 .
Stefanie Maurer & Lucas Ferrari de Andrade. (2020) NK Cell Interaction With Platelets and Myeloid Cells in the Tumor Milieu. Frontiers in Immunology 11.
Crossref
Melania Dovizio, Patrizia Ballerini, Rosa Fullone, Stefania Tacconelli, Annalisa Contursi & Paola Patrignani. (2020) Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System. International Journal of Molecular Sciences 21:24, pages 9585.
Crossref
Mihnea P. Dragomir, Vlad Moisoiu, Roxana Manaila, Barbara Pardini, Erik Knutsen, Simone Anfossi, Moran Amit & George A. Calin. (2020) A Holistic Perspective: Exosomes Shuttle between Nerves and Immune Cells in the Tumor Microenvironment. Journal of Clinical Medicine 9:11, pages 3529.
Crossref
Iluja Gautam, Zachary Storad, Louis Filipiak, Chadwick Huss, Claire K. Meikle, Randall G. Worth & Leah M. Wuescher. (2020) From Classical to Unconventional: The Immune Receptors Facilitating Platelet Responses to Infection and Inflammation. Biology 9:10, pages 343.
Crossref
Chaoqi Zhang, Zhen Zhang, Guochao Zhang, Zhihui Zhang, Yuejun Luo, Feng Wang, Sihui Wang, Yun Che, Qingpeng Zeng, Nan Sun & Jie He. (2020) Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma. Cancer Letters 479, pages 31-41.
Crossref
Tanya N Augustine. (2020) The aegis: platelets as biomarkers of tumor progression. Biomarkers in Medicine 14:7, pages 573-585.
Crossref
Yinlong Zhang, Shih‐Hsin Ho, Bozhao Li, Guangjun Nie & Suping Li. (2019) Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment. Medicinal Research Reviews 40:3, pages 1084-1102.
Crossref
Alessandra Zingoni, Elisabetta Vulpis, Luisa Loconte & Angela Santoni. (2020) NKG2D Ligand Shedding in Response to Stress: Role of ADAM10. Frontiers in Immunology 11.
Crossref
Stefanie Maurer, Hans-Georg Kopp, Helmut R. Salih & Korbinian N. Kropp. (2020) Modulation of Immune Responses by Platelet-Derived ADAM10. Frontiers in Immunology 11.
Crossref
Melissa Bersanelli, Stefania Scala, Paola Affanni, Licia Veronesi, Maria Eugenia Colucci, Giuseppe Luigi Banna, Alessio Cortellini & Francesco Liotta. (2020) Immunological insights on influenza infection and vaccination during immune checkpoint blockade in cancer patients. Immunotherapy 12:2, pages 105-110.
Crossref
Jinyu Zhang, Pablo Saenz-lopez Larrocha, Bin Zhang, Derek Wainwright, Payal Dhar & Jennifer D. Wu. (2019) Antibody targeting tumor-derived soluble NKG2D ligand sMIC provides dual co-stimulation of CD8 T cells and enables sMIC+ tumors respond to PD1/PD-L1 blockade therapy. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Behnaz Valipour, Kobra Velaei, Ali Abedelahi, Mohammad Karimipour, Masoud Darabi & Hojjatollah Nozad Charoudeh. (2019) NK cells: An attractive candidate for cancer therapy. Journal of Cellular Physiology 234:11, pages 19352-19365.
Crossref
Dominique C. Hinshaw & Lalita A. Shevde. (2019) The Tumor Microenvironment Innately Modulates Cancer Progression. Cancer Research 79:18, pages 4557-4566.
Crossref
Yalong Qi, Daixiang Liao, Xiaomin Fu, Quanli Gao & Yong Zhang. (2019) Elevated platelet-to-lymphocyte corresponds with poor outcome in patients with advanced cancer receiving anti-PD-1 therapy. International Immunopharmacology 74, pages 105707.
Crossref
Christopher D. Cluxton, Cathy Spillane, Sharon A. O'Toole, Orla Sheils, Clair M. Gardiner & John J. O'Leary. (2019) Suppression of Natural Killer cell NKG2D and CD226 anti-tumour cascades by platelet cloaked cancer cells: Implications for the metastatic cascade. PLOS ONE 14:3, pages e0211538.
Crossref
Kim Clar, Clemens Hinterleitner, Pascal Schneider, Helmut Salih & Stefanie Maurer. (2019) Inhibition of NK Reactivity Against Solid Tumors by Platelet-Derived RANKL. Cancers 11:3, pages 277.
Crossref
Zihai Li, Brian Riesenberg, Alessandra Metelli, Anqi Li & Bill X. Wu. 2019. Platelets. Platelets 547 561 .
Alexander P. Reiner & Andrew D. Johnson. 2019. Platelets. Platelets 99 126 .
Seila Lorenzo-Herrero, Alejandro López-Soto, Christian Sordo-Bahamonde, Ana Gonzalez-Rodriguez, Massimo Vitale & Segundo Gonzalez. (2018) NK Cell-Based Immunotherapy in Cancer Metastasis. Cancers 11:1, pages 29.
Crossref
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera & Brigitte M. Pützer. (2018) Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 53, pages 90-109.
Crossref
Laura Chiossone, Pierre-Yves Dumas, Margaux Vienne & Eric Vivier. (2018) Natural killer cells and other innate lymphoid cells in cancer. Nature Reviews Immunology 18:11, pages 671-688.
Crossref
Lorenzo Galluzzi, Timothy A. Chan, Guido Kroemer, Jedd D. Wolchok & Alejandro López-Soto. (2018) The hallmarks of successful anticancer immunotherapy. Science Translational Medicine 10:459.
Crossref
Dominik Schmiedel & Ofer Mandelboim. (2018) NKG2D Ligands–Critical Targets for Cancer Immune Escape and Therapy. Frontiers in Immunology 9.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.